Montecas L Syrup is a fixed-dose combination medication designed to provide rapid and sustained relief from symptoms of allergies and asthma. The syrup contains a unique combination of levocetirizine, a second-generation antihistamine, and montelukast, a leukotriene receptor antagonist. The levocetirizine component (2.5mg) helps to alleviate symptoms of allergic rhinitis, including nasal congestion, sneezing, and itchy nose and eyes, while the montelukast component (4mg) works to prevent bronchospasm and reduce inflammation in the airways. This combination therapy provides a comprehensive approach to managing symptoms of both allergies and asthma, making it an effective treatment option for patients experiencing concurrent respiratory and allergic symptoms. The syrup is administered orally, with the recommended dose being 5mL (containing 2.5mg of levocetirizine and 4mg of montelukast) taken once daily. It is contraindicated in patients with known hypersensitivity to either levocetirizine or montelukast, and should be used with caution in patients with hepatic impairment or those taking other medications that may interact with the components of Montecas L Syrup.